RECOMBITEK Oral Bordetella vaccine is shown to be effective against canine infectious tracheobronchitis caused by Bordetella bronchiseptica. RECOMBITEK is administered in the dog's buccal cavity (inside the cheek). Clinical studies suggest that as a mucosal vaccine, it offers dogs a robust immune response after a single dose. Oral delivery may mean a less stressful experience without the unpleasant sneeze backs of alternative vaccines delivered through the nose. The packaging's flip-top vial cap allows for easy opening, and the safe, needle-free pipette simplifies the vaccination process while reducing risk of injury. RECOMBITEK vaccines, manufactured by Merial, are backed by the Pet Vaccines Customer Satisfaction Guarantee.